Instructions for Heparin (Heparin sodium) gel 30 gr
Release Form:
Outdoor gel
Description:
The gel for external application is transparent or almost transparent, colorless or slightly yellowish, with a specific smell.
100 g
sodium heparin 100,000 ME
Auxiliary substances: methylparhydroxybenzoate - 0.15 g, carbomer 940 - 1.25 mg, trometamol - 0.85 g, ethanol 96% (ethyl rectifiated alcohol) - 2 4 g, lavender oil - 0.02 g, orange oil (nonoli oil) - 0.01 g, water purified - up to 100 g.
ATX codes
C05BA03 Heparin
Pharmacological groups / Group membership:
Drug with anti-rombotic effect for external use
Active substance
sodium heparin
Pharmacy Group
Direct-action anticoagulant for local use
Pharmaceuticals:
Direct anticoagulant for outdoor use. Local anti-rombotic, anti-exudative, moderate anti-inflammatory action is performed when externally applied. Blocks the formation of the trombin, depresses the activity of the hyaluronidase, activates the fibrinolithic properties of the blood. Heparin penetrating through the skin reduces inflammatory process and has anti-thrombotic effect, improves microcirculation and activates tissue exchange, thus speeding up the processes of hematom and clots absorption and reduction of tissue swelling.
Testimony:
Diseases of superficial veins: varicose veins, chronic venous insufficiency and related complications (superficial thrombophlebitis, superficial periflebit); blunt injuries and soft tissue contusions; subcutaneous hematomas (including hematoma after phlebectomy); localized infiltrations and soft tissue swelling.
How to use, course and dosage
outwardly. Sodium heparin in the appropriate medicinal form is applied to the skin. Apply 1-3 times/day daily before the disappearance of inflammatory phenomena, on average from 3 to 7 days.
Drug Interaction:
A substance for external use containing sodium heparin is not recommended to be mixed with other means for external use.
Simultaneous application with NPAs, tetracyclines, antihistamine means is not recommended.
Co-application with oral anticoagulants can cause protrombin time elongation.
Use in pregnancy and breastfeeding
Use during pregnancy and breastfeeding is possible if the intended benefit for the mother exceeds the potential risk for the fetus. Sodium heparin doesn't penetrate through the placental barrier and into breast milk. Due to low intake of heparin in external application, does not have a systemic effect on the body.
Side Action:
In some cases: High-sensitivity reactions, which can be denigrated by the active substance, as well as the subsidiary substances included in the drug used - skin redness, skin itching, which usually occur after the drug is stopped.
Contraindications to use:
Increased sensitivity to sodium heparin, ulcerous-necrotic skin changes in the areas of intended drug use, traumatic damage to the integrity of skin cover, increased propensity for bleeding, thrombocytopenia, age up to 18.
Special Instructions:
It is not recommended to use in hemorrhages, when there are local pyo processes, and also to apply to open wounds, mucous membranes.
With special care should be used for high permeability of vessels.
Not recommended for deep veins trombosis.
For prolonged use of the drug in large areas of the skin and simultaneous use of indirect anticoagulants (including varfarin, atsenokumarol), control of the protrombin time and the time of blood folding should be monitored.
Application of elderly patients:
There are no special warnings.
Application of children:
The use of children and adolescents under 18 years of age is contraindicated.
Nozology (ICD codes)
Flybit and Trombophlebit
Variocose extension of lower limb veins
Venture Insufficiency (Chronic) (peripheral)
Outlet not classified in other headings
Surface injury to an unspecified area of the body (including the abdomen, the hemorrhage, the bruise, the hematoma, the bite of a nonpoisonous insect)
Bleeding and hematoma complicating the procedure, not classified in other categories
